series-c-plus
Stage
1
Investors
About
Procyrion develops Aortix™, a percutaneous mechanical circulatory support device designed to treat heart failure patients by increasing aortic flow and improving renal perfusion, currently in clinical trial stages.
Explore Procyrion's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.